The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation.

Front Oncol · 2018 · PMC6072851 · PMID 30101126

Europe PMC DOI

hedged sentences

0.1000

closest p · 2.0× alpha

0.1260

boldest claim

The sentences

approaching significancep = 0.10so close (0.05 < p ≤ 0.1)

Nonetheless we attempted to control for putative prognostic factors by including all variables achieving or approaching significance at the p = 0.10 level in multivariable Cox regression in addition to the main variables of interest (hyperglycemia and glucocorticoid usage).

also in 2,640 other papers

borderline significantp = 0.126not close (p > 0.1)

65.8%, p = 0.095) was borderline significant for decreased LRC, with similar trends on multivariable analysis (HR 1.636, p = 0.126) and for OS (HR 1.476, p = 0.130).

also in 11,409 other papers

borderline significancep = 0.126not close (p > 0.1)

Having any glucose measurement ≥130 mg/dL during chemoradiotherapy was associated with inferior outcomes, reaching borderline significance for locoregional control (adjusted HR 1.636, p = 0.126) and overall survival (adjusted HR 1.476, p = 0.130).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.